Actimis Pharmaceuticals Inc — Form D
Actimis Pharmaceuticals Inc of San Mateo, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-06-19. The offering totals $1.0M, of which $452K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-06-19
- Form: D
- Accession: 0001313836-17-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $452K
- Remaining: $548K
- Investors: 5
- Date of first sale: 2017-03-13
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-288964
Issuer
- Name: Actimis Pharmaceuticals Inc
- CIK: 0001313836
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 400 S. El Camino Real, Suite 1200, San Mateo, CA, 94402
- Phone: 650-401-2000
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Kevin Bacon | Director | Santa Ana, CA |
| Masaji Matsuoka | Director | San Mateo, CA |
| Peter McWilliams | Director | San Mateo, CA |
| Fred Middleton | Director | La Jolla, CA |
| Kevin Bacon | Executive Officer | Santa Ana, CA |
| Peter McWilliams | Executive Officer | San Mateo, CA |
More